Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Turner

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Molecular Psychiatry|June 23, 2026
Protein epigenetic scores derived in neonatal saliva as biomarkers of childhood cognitionRebekah Smikle, Katie Mckinnon, Kadi Vaher, et al.
Radiation Research|September 13, 2021
CytoRADx: A High-Throughput, Standardized Biodosimetry Diagnostic System Based on the Cytokinesis-Block Micronucleus AssayChris Capaccio, Jay R Perrier, Lídia Cunha, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Plos One|November 1, 2012
Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?Ashley M Miller, David Purves, Alex McConnachie, et al.
Frontiers in Psychology|June 11, 2025
Innovating through tradition: kava-<i>talanoa</i> as a culturally aligned medico-behavioral therapeutic approach to amelioration of PTSD symptomsS Apo Aporosa, Dennis Itoga, Julia Ioane, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Ebiomedicine|May 21, 2024
Sialic acid blockade inhibits the metastatic spread of prostate cancer to boneKirsty Hodgson, Margarita Orozco-Moreno, Emily Archer Goode, et al.
American Journal of Human Genetics|July 17, 2020
Bi-allelic Mutations in M1AP Are a Frequent Cause of Meiotic Arrest and Severely Impaired Spermatogenesis Leading to Male InfertilityMargot J Wyrwoll, Şehime G Temel, Liina Nagirnaja, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Molecular Psychiatry|June 23, 2026
Protein epigenetic scores derived in neonatal saliva as biomarkers of childhood cognitionRebekah Smikle, Katie Mckinnon, Kadi Vaher, et al.
Radiation Research|September 13, 2021
CytoRADx: A High-Throughput, Standardized Biodosimetry Diagnostic System Based on the Cytokinesis-Block Micronucleus AssayChris Capaccio, Jay R Perrier, Lídia Cunha, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Plos One|November 1, 2012
Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?Ashley M Miller, David Purves, Alex McConnachie, et al.
Frontiers in Psychology|June 11, 2025
Innovating through tradition: kava-<i>talanoa</i> as a culturally aligned medico-behavioral therapeutic approach to amelioration of PTSD symptomsS Apo Aporosa, Dennis Itoga, Julia Ioane, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Ebiomedicine|May 21, 2024
Sialic acid blockade inhibits the metastatic spread of prostate cancer to boneKirsty Hodgson, Margarita Orozco-Moreno, Emily Archer Goode, et al.
American Journal of Human Genetics|July 17, 2020
Bi-allelic Mutations in M1AP Are a Frequent Cause of Meiotic Arrest and Severely Impaired Spermatogenesis Leading to Male InfertilityMargot J Wyrwoll, Şehime G Temel, Liina Nagirnaja, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 8